Niacin Plus Statin to Prevent Vascular Events

Stopped AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.

Conditions

• Cardiovascular Diseases
• Heart Diseases
• Cerebrovascular Accident
• Coronary Disease
• Atherosclerosis
• Myocardial Infarction

Interventions

• DRUG: Extended release niacin
• DRUG: Simvastatin

Sponsor

Axio Research. LLC

Collaborators

• [object Object]
• [object Object]